Keywords: Sanofi-Aventis, Genzyme, M&A, Inrceased offer

Genzyme finally agrees takeover deal, as Sanofi-Aventis ups its offer to $74/share plus CVR

Article | 16 February 2011

Confirming recent speculation French drug major Sanofi-Aventis (Euronext: SAN) and US biotech Genzyme (Nasdaq: GENZ) have finally reached agreement on ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Sanofi-Aventis

Genzyme

Go to company listing